RadNet Inc (RDNT)

Currency in USD
76.35
-0.96(-1.24%)
Closed·
75.25-1.10(-1.44%)
·
RDNT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
75.8478.14
52 wk Range
50.8285.84
Key Statistics
Prev. Close
77.31
Open
76.87
Day's Range
75.84-78.14
52 wk Range
50.82-85.84
Volume
632.88K
Average Vol. (3m)
829.22K
1-Year Change
13.195%
Book Value / Share
13.94
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RDNT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
92.88
Upside
+21.64%
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings downwards for the upcoming period

RadNet Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 92.88
(+21.64% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Buy94.00+23.12%90.00MaintainAug 11, 2026
B.Riley
Buy96.00+25.74%83.00MaintainAug 11, 2026
Truist Securities
Buy90.00+17.88%-MaintainAug 10, 2026
Barclays
Buy65.00-14.87%70.00MaintainMay 20, 2026
B.Riley
Buy83.00+8.71%87.00MaintainMay 01, 2026

RadNet Inc SWOT Analysis


Financial Ambitions
Management targets 11-13% annual revenue growth through 2028 with margin expansion of 100-150 basis points, driven by advanced imaging volume acceleration
Analyst Outlook
Price targets range from $65 to $100 with Strong Buy consensus, reflecting confidence despite screening challenges and short seller scrutiny
AI-Powered Growth
Strategic GE HealthCare partnership aims to commercialize DeepHealth's artificial intelligence portfolio domestically and internationally, diversifying revenue streams
Screening Headwinds
New JAMA guidelines recommend risk-based breast cancer screening, potentially reducing mammogram volumes by 40-45%, challenging RadNet's core business model
Read full SWOT analysis

RadNet Inc Earnings Call Summary for Q2/2026

  • RadNet Q2 2026 EPS of $0.29 beat estimates by 45%; revenue of $622.7M topped forecasts by 2.08%, driving shares up 6.1% after-hours.
  • Total revenue rose 25% YoY to $622.7M; adjusted EBITDA climbed 22.7% to record $99.7M, with imaging center EBITDA margin up 17 basis points.
  • Digital health revenue surged 56.5% YoY to $32.4M; annual recurring revenue nearly doubled to $105.5M, expected to reach $140M by year-end.
  • Company raised FY 2026 guidance: imaging center revenue to $2.37B-$2.42B, adjusted EBITDA to $345M-$358M, free cash flow to $115M-$125M.
  • AI deployment accelerating: 15% of volumes through AI auto-draft by end-2026, targeting over 50% by Q2 2027; new breast ultrasound AI cleared.
Last Updated: 08/10/2026, 12:16 PM
Read Full Transcript

Earnings

Latest Release
Aug 10, 2026
EPS / Forecast
0.29 / 0.20
Revenue / Forecast
622.7M / 610.01M
EPS Revisions
Last 90 days

RDNT Income Statement

Compare RDNT to Peers and Sector

Metrics to compare
RDNT
Peers
Sector
Relationship
P/E Ratio
−284.5x4.2x−0.4x
PEG Ratio
7.880.120.00
Price / Book
5.5x3.4x2.6x
Price / LTM Sales
2.6x1.2x3.1x
Upside (Analyst Target)
25.1%17.8%48.3%
Fair Value Upside
Unlock8.2%6.2%Unlock

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
41.38M52.62%3.16B
Other Institutional Investors
39.74M47.38%3.03B
Public Companies & Retail Investors
0.000.00%0.00
Total
81.11M100.00%6.19B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.13.94%10,957,808836,629
RTW Investments, LP5.45%4,285,000327,160

People Also Watch

73.69
GEHC
-0.14%
325.83
COHR
-0.43%
126.24
NRG
+5.42%
451.51
ETN
-0.40%
167.11
APH
+0.82%

FAQ

What Is the RadNet (RDNT) Stock Price Today?

The RadNet stock price today is 76.35 USD.

What Stock Exchange Does RadNet Trade On?

RadNet is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for RadNet?

The stock symbol for RadNet is "RDNT."

What Is the RadNet Market Cap?

As of today, RadNet market cap is 6.01B USD.

What Is RadNet's Earnings Per Share (TTM)?

The RadNet EPS (TTM) is -0.27.

When Is the Next RadNet Earnings Date?

RadNet will release its next earnings report on Nov 11, 2026.

From a Technical Analysis Perspective, Is RDNT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has RadNet Stock Split?

RadNet has split 1 times.

How Many Employees Does RadNet Have?

RadNet has 9060 employees.

What is the current trading status of RadNet (RDNT)?

As of Aug 16, 2026, RadNet (RDNT) is trading at a price of 76.35 USD, with a previous close of 77.31 USD. The stock has fluctuated within a day range of 75.84 USD to 78.14 USD, while its 52-week range spans from 50.82 USD to 85.84 USD.

What Is RadNet (RDNT) Price Target According to Analysts?

The average 12-month price target for RadNet is 92.88 USD, with a high estimate of 105 USD and a low estimate of 65 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +21.64% Upside potential.

What Is the RDNT Premarket Price?

RDNT's last pre-market stock price is 76.92 USD. The pre-market share volume is 630.00, and the stock has decreased by -0.39, or -0.50%.

What Is the RDNT After Hours Price?

RDNT's last after hours stock price is 75.25 USD, the stock has decreased by -1.10, or -1.44%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.